By indication / Bone metastases and bone lesions
Bone metastases and bone lesions
3 imaging agents and 9 therapeutic agents reported for this indication. Stage reflects how far each has been taken, not what is available in any given country.
Imaging
| Agent | Isotope | Stage | Syntheses |
|---|---|---|---|
| [18F]NaF | F-18 | Approved | 12 |
| [68Ga]Ga-BPAMD paired with [161Tb]Tb-BPAMD | Ga-68 | — | 6 |
| [89Zr]Zr-DFO-girentuximab | Zr-89 | clinical proof-of-concept / prospective pilot study | 4 |
Therapy
| Agent | Isotope | Stage | Syntheses |
|---|---|---|---|
| [223Ra]Ra-RaCl2 | Ra-223 | approved | 14 |
| [153Sm]Sm-EDTMP | Sm-153 | approved | 10 |
| [177Lu]Lu-LuPSMA-617 | Lu-177 | approved | 8 |
| [177Lu]Lu-FAP-2286 paired with [68Ga]Ga-FAP-2286 | Lu-177 | first-in-human | 4 |
| [177Lu]Lu-BPAMD paired with [68Ga]Ga-BPAMD | Lu-177 | — | 2 |
| [161Tb]Tb-BPAMD paired with [68Ga]Ga-BPAMD | Tb-161 | — | 1 |
| [225Ac]Ac-DOTAZOL | Ac-225 | preclinical | 1 |
| [211At]At-astatobenzamide-N-3-hydroxypropylidene-3 | At-211 | preclinical | 1 |
| [153Sm]Sm-BPAMD paired with [68Ga]Ga-BPAMD | Sm-153 | preclinical |
Have a question?Reagents, modules, introductions to manufacturers or to specialists in your region — tell us what you need.
Get in touch